Cancer/testis antigen CAGE mediates osimertinib resistance in non-small cell lung cancer cells and predicts poor prognosis in patients with pulmonary adenocarcinoma

CAGE, a cancer/testis antigen, was originally isolated from the sera of patients with gastric cancers. Previously, we have shown the role of CAGE in resistance to chemotherapy and target therapy. The aim of this study was to investigate the role of CAGE in osimertinib resistance and determine the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeon, Minjeong, Lee, Hankyu, Yeo, Jeongseon, Jeong, Myeong Seon, Jung, Hyun Suk, Lee, Hyerim, Shim, Kyeonghee, Jo, Hyein, Jeon, Doyong, Koh, Jaemoon, Jeoung, Dooil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514060/
https://www.ncbi.nlm.nih.gov/pubmed/37735252
http://dx.doi.org/10.1038/s41598-023-43124-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514060/
https://www.ncbi.nlm.nih.gov/pubmed/37735252
http://dx.doi.org/10.1038/s41598-023-43124-8

Ejemplares similares